Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.
Summary
- On April 30, 2024, Eric Sievers, the Chief Medical Officer of BioAtla, Inc., had 572 shares of common stock withheld by the issuer to cover income tax obligations.
- The price per share for the transaction was $2.26.
- Following the transaction, Sievers beneficially owns 209,850 shares of BioAtla, Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on a routine transaction related to executive compensation and tax obligations; it doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders and their holdings in the company. This filing indicates a standard tax withholding procedure related to the vesting of restricted stock units, which is a common form of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction where shares were withheld to cover tax obligations. |
| 05/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.